CPRX R&D to Revenue
Catalyst Pharmaceuticals Inc · R&D to Revenue
CPRX R&D to Revenue
Latest reported2.16%period ending
CPRX FY R&D/Revenue (0.00% → 2.16%)
Latest values, visible window
High-resolution chart · PNG
CPRX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 2.1578% | |
| 2.5721% | |
| 23.3925% | |
| 9.2384% | |
| 12.0256% | |
| 13.8545% | |
| 18.4183% | |
| 3,983.8408% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 471.7749% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |